Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Lack of engagement with psychological therapies
Lactate in blood, psychotropic agent effects
Lamotrigine
borderline personality disorder
clozapine augmentation
in overdose
life-threatening cutaneous reactions
restarting after period of non-compliance
target range
Laxative misuse/abuse
Biochemical and haematological effects of psychotropics
Eating disorders
Laxatives
Acting on clozapine plasma concentration results
Clozapine: common adverse effects
Clozapine-induced gastrointestinal hypomotility
Initiation of clozapine in the community
Safer prescribing for physical conditions in dementia
Learning difficulties
capacity and consent
epilepsy comorbidity
general considerations
Learning disabilities
prescribing practice
Legal issues
Lemborexant
in overdose
managing sleep disturbance in dementia
use in patients with hepatic impairment
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Leukopenia, psychotropic agent effects
Levetiracetam, for tardive dyskinesia
Levomepromazine
Quick reference for licensed maximum doses
Relative adverse effects - a rough guide
Lewy body dementia
Dementia
Parkinson's disease
Libido
Licensed maximum doses of antipsychotics, according to US Food and Drug Administration labelling, where available
Linaclotide, for constipation treatment
Linear dose reductions of olanzapine cause increasingly large reductions in D2 dopaminergic receptor blockade.
Linear reductions of dose cause increasingly large reductions in effect on GABA-A receptor occupancy.
Linear reductions of dose cause increasingly large reductions in effect on receptor targets, probably associated with more withdrawal effects.
Lipoproteins in blood, psychotropic agent effects
Liraglutide, for antipsychotic-induced weight gain
Lisdexamfetamine
attention deficit hyperactivity disorder in adults
borderline personality disorder
bulimia nervosa/binge eating disorder
Lithium: clinically relevant drug interactions
Lithium: prescribing and monitoring
Lithium plasma levels
Lithium use with
Lithium
liver function tests (LFTs)
interpretation
monitoring to access drug effects
Lofepidrine, in overdose
Lofexidine, clozapine-induced hypersalivation
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 44